World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 20 June 2023
Main ID:  ISRCTN10214981
Date of registration: 28/04/2017
Prospective Registration: No
Primary sponsor: European Joint Programming Initiative “A Healthy Diet for a Healthy Life” (JPI - HDHL)
Public title: Effect of a polyphenol-rich diet on leaky gut in the elderly
Scientific title: Gut and blood microbiomics for studying the effect of a polyphenol-rich dietary pattern on intestinal permeability in the elderly
Date of first enrolment: 01/06/2016
Target sample size: 60
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN10214981
Study type:  Interventional
Study design:  Randomised controlled cross over study (Prevention)  
Phase:  Not Applicable
Countries of recruitment
Italy
Contacts
Name: Patrizia    Riso
Address:  DeFENS - Department of Food, Environmental and Nutritional Sciences Division of Human Nutrition University of Milan 20133 Milan Italy
Telephone: +39 0250316726
Email: patrizia.riso@unimi.it
Affiliation: 
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. Age > 60 years old
2. Intestinal Permeability evaluated by Zonulin serum level
3. Adequate nutritional status evaluated with Mini Nutritional Assessment (MNA) score =24
4. Good cognitive status tested with Mini Mental State Evaluation (MMSE) score =24
5. Self-sufficiency assessed with validated tests (e.g. Barthel index - activities of daily living, Tinetti balance assessment)

Exclusion criteria:
1. Celiac disease
2. Severe liver disease with cirrhosis
3. Severe renal insufficiency (dialysis)
4. Presence of Chronic Obstructive Pulmonary severe COPD (oxygen therapy for many hours a day) or severe heart failure, i.e. class III or IV NYHA - New York Heart Association
5. Antibiotic treatment
6. Malignant tumor that required treatment in the previous 2 years


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Intestinal permeability (IP)
Digestive System
Intestinal permeability (IP)
Intervention(s)

Based on a computer randomization plan, subjects are randomized to receive the two study diets in a random order. Participants follow the diets for eight weeks, followed by an eight week washout period where they follow their regular diet and then the other diet for eight weeks.

Polyphenol-rich (PR)-diet: Participants consume a diet developed to double the amount of polyphenols intake (as recorded in the population under study) providing three portion of polyphenol-rich food products daily (i.e about 750 mg of total polyphenols are added to the amount regularly introduced). The following polyphenol-rich products have been considered in the PR-diet: berries and derived products, blood oranges and derived products, pomegranate juice, renetta apple and purée, green tea and dark chocolate products.

The control diet (C-diet): Participants consume a comparable diet for eight weeks without thepolyphenol-rich products.

Before and after each study diet period (at baseline, 8, 16 and 24 weeks), participants provide blood, urine and stool samples.
Primary Outcome(s)
Intestinal permeability is evaluated by measuring Zonulin serum levels using an ELISA kit at baseline, 8, 16 and 24 weeks.
Secondary Outcome(s)

1. Fecal microbiota composition evaluated by 16S rRNA gene profiling with MiSeq-Illumina platform at baseline, 8, 16 and 24 weeks
2. Short chain fatty acids and polyphenol-derived metabolites measured with LC-MS system at baseline, 8, 16 and 24 weeks
3. Diet-induced changes in microbiota metabolism performed by NMR at baseline, 8, 16 and 24 weeks
4. LC-MS analysis are used for faecal water at baseline, 8, 16 and 24 weeks
5. Total blood bacterial load are assessed through a quantitative real-time PCR; taxomic profile investigated by 16S rRNA gene profiling with MiSeq-Illumina platform at baseline, 8, 16 and 24 weeks
6. Inflammatory markers, oxidative stress and related markers e.g. vascular cell adhesion molecule (VCAM)-1 and intracellular adhesion molecule (ICAM)-1 performed through ELISA kit at baseline, 8, 16 and 24 weeks
7. DNA damage assessed through Comet Assay at baseline, 8, 16 and 24 weeks
8. Endotoxin by Limulus Amebocyte Lysate (LAL) assay assessed to evaluate the inflammatory process and oxidative stress modulation at baseline, 8, 16 and 24 weeks
9. Metabolomic analysis will be performed on HPLC-ESI-Q-ToF-MS and NMR to understand the interaction of the polyphenol rich diet with the secondary metabolites of microbiota at baseline, 8, 16 and 24 weeks
Secondary ID(s)
N/A
Source(s) of Monetary Support
Ministero delle Politiche Agricole Alimentari e Forestali, Biotechnology and Biological Sciences Research Council, PCIN-2015-238 Ministry of Economy, Industry and Competitiveness, Spanish government
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Ethics Committee of the University of Milan, 15/02/2016, ref: 6/16 CE_15.02.16_Verbale_All-7
Results
Results available: Yes
Date Posted:
Date Completed: 31/12/2019
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history